Scientific article
English

GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring

Published in

Journal of rheumatology, vol. 41, no. 6, p. 1224-1226

Publication date

2014

Abstract

It is now well established that psoriatic disease is associated with increased cardiovascular (CV) risk. Screening guidelines and expert recommendations for CV risk factors have been published, but these are primarily directed to specific specialists (e.g., cardiologists or diabetologists) and may not be well known in common practice. The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and other organizations are interested in adapting current comorbidity screening guidelines for use by dermatologists and rheumatologists. The resulting checklists and algorithms will need to be evaluated for practicability and performance.

Keywords

  • Arthritis, Psoriatic/complications
  • Cardiovascular Diseases/diagnosis/etiology
  • Humans
  • Psoriasis/complications
  • Risk Factors

UNIGE research groups

Citation (ISO format)

BOEHNCKE, Wolf-Henning. GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring. In: Journal of rheumatology, 2014, vol. 41, n° 6, p. 1224–1226. doi: 10.3899/jrheum.140175

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0315-162X
562views
0downloads

Technical informations

Creation

30/10/2015 16:32:00

First validation

30/10/2015 16:32:00

Update

24/01/2025 16:05:43

Status update

24/01/2025 16:05:43

Last indexation

24/01/2025 16:10:32
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated